Patent · US Active

Kinase inhibitors and methods of use thereof

US8039639B2 · kind B2 · utility

2Cited by

50References

1Claims

0Family size

Assignee

Array BioPharma, Inc. · US

Inventors

Robert D. Groneberg · Boulder, US
Laurence E. Burges · Boulder, US
Darren Harvey · Boulder, US
Ellen Laird · Longmont, US
Mark Munson · Bound Brook, US
James P. Rizzi · Niwot, US
Martha E. Rodriguez · Boulder, US
Charles Todd Eary · Stamford, US
Daniel J. Watson · Lafayette, US

Key dates

Filing date	Feb 3, 2011
Grant date	Oct 18, 2011
Priority date	—
Expiry date	Feb 3, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D231/56
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound of Formula IIand salts thereof are useful in the preparation of a compound of Formula Iand pharmaceutically acceptable salts and prodrugs thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.